← All organizations
Highest phase reached
Phase 4
First clinical trial
Dec 1, 2016Last known activity
Oct 1, 2024
Timeline
No events for the selected filters.
Drugs by trial phase (39 distinct, 29 trials)
Phase 4 (18 own, 0 via acquisition)
Phase 3 (9 own, 0 via acquisition)
Phase 2 (1 own, 0 via acquisition)
Other trials (11 own, 0 via acquisition)
Indications
Recent trials (50)
- NCT06510673CollaboratorN/AOct 1, 2024
- NCT06491680Lead sponsorPhase 4Sep 10, 2024
- NCT06491680Sponsor investigatorPhase 4Sep 10, 2024
- NCT06535529Lead sponsorPhase 3Aug 24, 2024
- NCT06535529Sponsor investigatorPhase 3Aug 24, 2024
- NCT06466421OfficialPhase 4Jul 1, 2024
- NCT06378021Sponsor investigatorPhase 3Mar 14, 2024
- NCT06378021Lead sponsorPhase 3Mar 14, 2024
- NCT06298110Lead sponsorPhase 2/Phase 3Mar 10, 2024
- NCT06298110OfficialPhase 2/Phase 3Mar 10, 2024
- NCT06298110Sponsor investigatorPhase 2/Phase 3Mar 10, 2024
- NCT06286059Sponsor investigatorPhase 2/Phase 3Mar 7, 2024
- NCT06286059Lead sponsorPhase 2/Phase 3Mar 7, 2024
- NCT06286059OfficialPhase 2/Phase 3Mar 7, 2024
- NCT06281483CollaboratorN/AJan 1, 2024
Details
- Last known activity
- Oct 1, 2024